Loading…
Product type
Everolimus is a potent immunosuppressant and anti-cancer agent that belongs to the class of drugs known as mTOR inhibitors. It is derived from a natural product, specifically a fermentation product of the bacterium Streptomyces hygroscopicus. Everolimus works by inhibiting the mammalian target of rapamycin (mTOR), a key regulator of cell growth and proliferation, making it effective in various therapeutic areas including oncology and organ transplantation.
| Chemical formula | C53H83N1O14P |
| Molecular weight | 958.2 g/mol |
| Formulation type | Oral tablets and injectable solutions |
| Purity | Typically ≥ 98% |
| Storage conditions | Store at room temperature, protected from light |
When purchasing everolimus, buyers should consider the required purity levels and the specific formulation needed for their application, whether it be for oral or injectable use. It's important to specify the desired quantity and any necessary certifications, such as Good Manufacturing Practice (GMP) compliance. Additionally, buyers should inquire about stability data and shelf life to ensure product efficacy.
Get quotes for Everolimus
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
Everolimus is used primarily in oncology and for preventing organ rejection in transplant patients.
It can be administered orally in tablet form or via injection.
Common side effects may include mouth sores, infections, and gastrointestinal issues.
Long-term use should be monitored by a healthcare professional due to potential side effects.
Consider purity, formulation type, and supplier certifications.
Yes, it is often used in combination with other cancer therapies or immunosuppressants.